Antimicrobial activity and stability of protonectin with D-amino acid substitutions.

about

Antimicrobial activity and stability of protonectin with D-amino acid substitutions.

Item

http://www.wikidata.org/entity/Q40291998

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Antimicrobial activity and stability of protonectin with D-amino acid substitutions.

@en

type

Item

label

Antimicrobial activity and stability of protonectin with D-amino acid substitutions.

@en

prefLabel

Antimicrobial activity and stability of protonectin with D-amino acid substitutions.

@en

P1476

Antimicrobial activity and stability of protonectin with D-amino acid substitutions

@en

P2093

Fengjing Jia

http://www.w3.org/2001/XMLSchema#string

Hailin Wang

http://www.w3.org/2001/XMLSchema#string

Jinhuan Su

http://www.w3.org/2001/XMLSchema#string

Jinxiu Peng

http://www.w3.org/2001/XMLSchema#string

Kairong Wang

http://www.w3.org/2001/XMLSchema#string

Qingjun Wang

http://www.w3.org/2001/XMLSchema#string

Ranran Zhu

http://www.w3.org/2001/XMLSchema#string

Rui Wang

http://www.w3.org/2001/XMLSchema#string

Shuai Qiu

http://www.w3.org/2001/XMLSchema#string

Wenjin Yan

http://www.w3.org/2001/XMLSchema#string

P2860

Antimicrobial peptides of multicellular organisms

The lantibiotic nisin, a special case or not?

Activities of synthetic hybrid peptides against anaerobic bacteria: aspects of methodology and stability

Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.

Mechanisms of antimicrobial peptide action and resistance.

From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides.

Antimicrobial peptides in animals and their role in host defences.

Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity

Introduction of a lysine residue promotes aggregation of temporin L in lipopolysaccharides and augmentation of its antiendotoxin property.

The FDA reboot of antibiotic development.

P304

392-402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PSC.2989

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jiayi Wang

P577

2017-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28299840

http://www.w3.org/2001/XMLSchema#string